During the past decade, Mathias-Spital Rheine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mathias-Spital Rheine" #1 sponsor was "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Dominik Paul Modest" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Maquet Cardiovascular" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mathias-Spital Rheine" #1 collaborator was "German Research Foundation" with 1 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Mathias-Spital Rheine" are "Cholangiocarcinoma" (2 trials), "Gallbladder Cancer" (2 trials), "Hepatocellular Cancer" (2 trials), "Oesophageal Cancer" (2 trials) and "Pancreatic Cancer" (2 trials). Many other conditions were trialed in "Mathias-Spital Rheine" in a lesser frequency.

Most popular intervention types in "Mathias-Spital Rheine" are "Drug" (3 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (1 trials), "Erlotinib" (1 trials), "FUSION Vascular Graft" (1 trials), "FoundationOne®CDx and FoundationOne®Liquid" (1 trials) and "Sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mathias-Spital Rheine" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Mathias-Spital Rheine". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mathias-Spital Rheine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mathias-Spital Rheine, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Mathias-Spital Rheine has several departments that took part in Clinical trials: "Jakobi Krankenhaus" - 5 trials